48 related articles for article (PubMed ID: 32839916)
1. Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors.
Withrow DR; Schonfeld SJ; Curtis RE; Morton LM; Cook MB; Butler EN; Berrington de González A
Cancer Causes Control; 2020 Nov; 31(11):1011-1019. PubMed ID: 32839916
[TBL] [Abstract][Full Text] [Related]
2. Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors.
Brandt C; Vo JB; Gierach GL; Cheng I; Torres VN; Lawrence WR; McCullough LE; Veiga LHS; Berrington de González A; Ramin C
Int J Cancer; 2024 Apr; ():. PubMed ID: 38685564
[TBL] [Abstract][Full Text] [Related]
3. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
[TBL] [Abstract][Full Text] [Related]
4. Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study.
Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
Cancer Causes Control; 2024 Apr; 35(4):647-659. PubMed ID: 38001335
[TBL] [Abstract][Full Text] [Related]
5. Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016.
Mukand NH; Zolekar A; Ko NY; Calip GS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2220-2229. PubMed ID: 32856609
[TBL] [Abstract][Full Text] [Related]
6. Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study.
Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
J Geriatr Oncol; 2024 Apr; 15(3):101748. PubMed ID: 38493533
[TBL] [Abstract][Full Text] [Related]
7. Coupling of prostate and thyroid cancer diagnoses in the United States.
Tomaszewski JJ; Uzzo RG; Egleston B; Corcoran AT; Mehrazin R; Geynisman DM; Ridge JA; Veloski C; Kocher N; Smaldone MC; Kutikov A
Ann Surg Oncol; 2015 Mar; 22(3):1043-9. PubMed ID: 25205302
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Health Status, Chronic Conditions, and Behavioral Risk Factors Among Prostate Cancer Survivors, United States, 2015.
Atere-Roberts J; Gray SC; Hall IJ; Smith JL
Prev Chronic Dis; 2021 Apr; 18():E39. PubMed ID: 33890569
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
Kwon WA; Joung JY; Lim J; Oh CM; Jung KW; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
BMC Cancer; 2018 May; 18(1):617. PubMed ID: 29855390
[TBL] [Abstract][Full Text] [Related]
10. Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019.
Leung TH; El Helali A; Wang X; Ho JC; Pang H
Cancer Med; 2023 Dec; 12(24):22316-22324. PubMed ID: 38063337
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Cancer Incidence Rates by Race and Ethnicity: Results from the Surveillance, Epidemiology, and End Results (SEER) Registry (2000-2019).
Tosakoon S; Lawrence WR; Shiels MS; Jackson SS
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473350
[TBL] [Abstract][Full Text] [Related]
12. Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers.
Rusner C; Streller B; Stegmaier C; Trocchi P; Kuss O; McGlynn KA; Trabert B; Stang A
Asian J Androl; 2014; 16(2):285-9. PubMed ID: 24407180
[TBL] [Abstract][Full Text] [Related]
13. Trends in suicide mortality among prostate cancer survivors in the United States, 1975-2019.
Wan H; Zhan X; Xiong S; Chen T; Liu X; Deng X; Xu S; Fu B
BMC Public Health; 2024 Jan; 24(1):101. PubMed ID: 38183028
[TBL] [Abstract][Full Text] [Related]
14. Geospatial analysis of multiple cancers in individuals in the US, 2004-2014.
Scott LC; Kuo TM; Il'yasova D; Mobley LR
Ann Cancer Epidemiol; 2021 Mar; 5():. PubMed ID: 33880445
[TBL] [Abstract][Full Text] [Related]
15. Risk and Prognostics of Second Primary Cancer After Prostate Radiation Therapy.
Liu EK; Daniels TB; Lischalk JW; Oh C; Haas JA; Evans AJ; Byun DJ
Urol Pract; 2024 Jan; 11(1):146-152. PubMed ID: 37917577
[TBL] [Abstract][Full Text] [Related]
16. Rationale, Procedures, and Response Rates for a Pilot Study to Sample Cancer Survivors for NCI's Health Information National Trends Survey: HINTS-SEER 2021.
Blake KD; Moser RP; Murray AB; Davis T; Cantor D; Caporaso A; West M; Bentler S; McKinley M; Shariff-Marco S; Wiggins C; Vanderpool RC
J Health Commun; 2024 Feb; 29(2):119-130. PubMed ID: 38131342
[TBL] [Abstract][Full Text] [Related]
17. Second malignancies among elderly survivors of cancer.
VanderWalde AM; Hurria A
Oncologist; 2011; 16(11):1572-81. PubMed ID: 22042787
[TBL] [Abstract][Full Text] [Related]
18. Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study.
Zhang M; Li N; Ma K; Wang L; Cai Y; Liu Z
J Gastrointest Oncol; 2024 Apr; 15(2):747-754. PubMed ID: 38756627
[TBL] [Abstract][Full Text] [Related]
19. Incidence rates of bladder and kidney cancers among US military servicemen: comparison with the rates in the general US population.
Bytnar JA; McGlynn KA; Kern SQ; Shriver CD; Zhu K
Eur J Cancer Prev; 2024 Mar; ():. PubMed ID: 38568164
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Genomic Inflation Estimates in Genome-Wide Association Studies Using Genetically Identified Ancestry vs Self-Identified Race/Ethnicity in Prostate Cancer Patients in ELLIPSE Cohort.
Pagadala MS; Ryan S; Carter H; Javier-DesLoges J
J Urol; 2024 Mar; 211(3):465-468. PubMed ID: 38010907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
